Mr Nicholas Faure Walker, Consultant Urologist
Mr Nicholas Faure Walker
Consultant Urologist
Mr Nicholas Faure Walker BSc (Hons) FRCS (Urol) FEBU
Consultant Urologist
Mr Nicholas Faure Walker
Consultant Urologist BSc (Hons) FRCS (Urol) FEBU
Areas of expertise
- Benign prostate hyperplasia
- General urology
- Kidney stone disease & prevention
- Male and female incontinence
- Neurourology
Recommendations for Mr Faure Walker
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
Make an appointment
Address
-
The Prostate Centre
18 Devonshire Street, London, W1G 7AQ
-
The Princess Grace Hospital
42-52 Nottingham Place, London, W1U 5NY
-
HCA UK at The Shard
The Shard, 32 St Thomas Street, London, SE1 9BS
-
Telephone or video consultation
Virtual
About Mr Nicholas Faure Walker
GMC number: 7044314
Year qualified: 2009
Place of primary qualification: University of London
Mr Nicholas Faure Walker is a Consultant Urologist at The Princess Grace Hospital and The Prostate Centre. He has a specialist interest in female, functional, neurological, and urodynamic urology.
Mr Faure Walker is the educational lead for urology at the Princess Royal University Hospital in Orpington and an honorary senior lecturer in urology at King’s College London. He has published numerous papers and is regularly invited to speak at national and international conferences on both specialist and general aspects of urology.
He completed his surgical and urology specialty training in London and undertook a postgraduate fellowship in female, functional, and reconstructive urology at Concord Hospital in Australia. His contributions to the field have been recognised with awards from the Royal Society of Medicine, the British Association of Surgical Oncology, and the Association of Surgeons of Great Britain and Ireland. Additionally, he has worked in Sierra Leone and served as an expedition medic.
Mr Faure Walker is an active member of several professional organisations, including the International Continence Society (ICS), the European Association of Urology (EAU), the International Neurourology Society (INUS), and the British Association of Urological Surgeons (BAUS). He is also a member of the female and functional section of the EAU.
Mr Faure Walker has been serving in his current roles since his appointment, bringing extensive expertise and compassionate care to his patients.
Areas of expertise
- Artificial urinary sphincter
- Autologous fascial sling
- Benign prostate hyperplasia
- Bladder cancer
- Bladder instillation
- Bladder neck incision
- Bladder pain
- Bladder stones
- Bladder surgery
- Blood in urine (haematuria)
- Circumcision
- Colposuspension
- Cystoscopy
- Epididymal cysts
- Erectile dysfunction
- Female and reconstructive urology
- Foreskin and scrotal conditions
- Frenuloplasty (penis)
- Green light laser prostatectomy
- Hydrocelectomy
- Hydrocoele (collection of fluid around the testicle)
- Interstitial cystitis
- Kidney cysts
- Kidney stone prevention
- MRI of prostate
- Obstructive uropathy
- Orchidectomy
- Overactive bladder
- Postural orthostatic tachycardia syndrome (POTS)
- Prostate cancer diagnostics
- Prostatectomy (TURP)
- PSA testing
- Reconstructive surgery
- Rigid & flexible ureterorenoscopy and laser fragmentation of stones
- Testicular lumps & swellings
- Testicular pain
- Transurethral resection of a bladder tumour (TURBT)
- Ureteroscopy
- Urethral bulking agent
- Urge bladder suppression drills
- Urinary incontinence
- Urinary retention
- Urinary tract infections (UTIS)
- Urodynamics
- Urological cancers
- Vasectomy (male sterilization)
Professional memberships
Articles by Mr Nicholas Faure Walker
Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry
Initial outcomes of local anaesthetic freehand transperineal prostate biopsies in the outpatient setting
A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer